Jonathan C. Fox, See Remarks at Eidos Therapeutics, Inc. (EIDX), sold 16,420 shares at $55.00 ($903K) on 2020-01-15, disclosed to the SEC on 2020-01-16.
Open-market sale of $903k EIDX by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.01 | 6,420 | $353K | 39.1% |
| 2 | $55.01 | 6,420 | $353K | 39.1% |
| 3 | $55.00 | 3,580 | $197K | 21.8% |
| Total | $55.01 avg | 16,420 | $903K | 100% |
| Filing → |
| EIDX | SELL | 2020-09-18 | $579K | — | Filing → |
| EIDX | SELL | 2020-09-16 | $369K | — | Filing → |
| EIDX | SELL | 2020-07-09 | $250K | — | Filing → |